Original Article
Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies
Tofacitinib, un inhibidor oral de la cinasa Janus, en pacientes Mexicanos con Artritis Reumatoide: análisis de eficacia y seguridad de estudios fase 3 y de extensión a largo plazo
Ruben Burgos-Vargasa, Mario Cardielb, Daniel Xibilléc, César Pacheco-Tenad, Virginia Pascual-Ramose, Carlos Abud-Mendozaf, Ehab Mahgoubg, Mahboob Rahmanh,◊, Haiyun Fani, Ricardo Rojoi, Erika Garcíag,◊, Karina Santanaj,
Corresponding author
a Hospital General de México, Ciudad de México, Mexico
b Centro de Investigación Clínica de Morelia, Morelia, Mexico
c Servicios de Salud de Morelos, Morelos, Mexico
d Universidad Autónoma de Chihuahua, Chihuahua, Mexico
e Instituto Nacional de Ciencias, Ciudad de México, Mexico
f Hospital Central, San Luis Potosí, Mexico
g Pfizer Inc., Collegeville, PA, USA
j Pfizer Inc., Ciudad de México, Mexico
Ver másRead
8009
Timeswas read the article
2965
Total PDF
5044
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 May | 14 | 6 | 20 |
| 2025 April | 78 | 35 | 113 |
| 2025 March | 78 | 41 | 119 |
| 2025 February | 74 | 40 | 114 |
| 2025 January | 81 | 60 | 141 |
| 2024 December | 38 | 31 | 69 |
| 2024 November | 67 | 54 | 121 |
| 2024 October | 73 | 40 | 113 |
| 2024 September | 72 | 19 | 91 |
| 2024 August | 79 | 36 | 115 |
| 2024 July | 60 | 35 | 95 |
| 2024 June | 62 | 32 | 94 |
| 2024 May | 52 | 38 | 90 |
| 2024 April | 62 | 23 | 85 |
| 2024 March | 44 | 38 | 82 |
| 2024 February | 35 | 23 | 58 |
| 2024 January | 37 | 25 | 62 |
| 2023 December | 52 | 39 | 91 |
| 2023 November | 61 | 34 | 95 |
| 2023 October | 44 | 30 | 74 |
| 2023 September | 274 | 40 | 314 |
| 2023 August | 51 | 18 | 69 |
| 2023 July | 36 | 18 | 54 |
| 2023 June | 42 | 22 | 64 |
| 2023 May | 51 | 22 | 73 |
| 2023 April | 35 | 16 | 51 |
| 2023 March | 88 | 31 | 119 |
| 2023 February | 53 | 38 | 91 |
| 2023 January | 57 | 20 | 77 |
| 2022 December | 94 | 33 | 127 |
| 2022 November | 70 | 29 | 99 |
| 2022 October | 78 | 48 | 126 |
| 2022 September | 90 | 45 | 135 |
| 2022 August | 85 | 50 | 135 |
| 2022 July | 64 | 44 | 108 |
| 2022 June | 97 | 44 | 141 |
| 2022 May | 86 | 58 | 144 |
| 2022 April | 140 | 54 | 194 |
| 2022 March | 164 | 52 | 216 |
| 2022 February | 178 | 34 | 212 |
| 2022 January | 145 | 48 | 193 |
| 2021 December | 79 | 43 | 122 |
| 2021 November | 90 | 49 | 139 |
| 2021 October | 50 | 69 | 119 |
| 2021 September | 40 | 48 | 88 |
| 2021 August | 35 | 48 | 83 |
| 2021 July | 35 | 47 | 82 |
| 2021 June | 51 | 45 | 96 |
| 2021 May | 63 | 51 | 114 |
| 2021 April | 164 | 59 | 223 |
| 2021 March | 75 | 45 | 120 |
| 2021 February | 56 | 30 | 86 |
| 2021 January | 52 | 25 | 77 |
| 2020 December | 53 | 30 | 83 |
| 2020 November | 48 | 25 | 73 |
| 2020 October | 45 | 25 | 70 |
| 2020 September | 58 | 37 | 95 |
| 2020 August | 57 | 24 | 81 |
| 2020 July | 51 | 33 | 84 |
| 2020 June | 71 | 11 | 82 |
| 2020 May | 79 | 24 | 103 |
| 2020 April | 62 | 23 | 85 |
| 2020 March | 58 | 33 | 91 |
| 2020 February | 46 | 32 | 78 |
| 2020 January | 70 | 30 | 100 |
| 2019 December | 53 | 34 | 87 |
| 2019 November | 44 | 14 | 58 |
| 2019 October | 50 | 22 | 72 |
| 2019 September | 83 | 32 | 115 |
| 2019 August | 45 | 31 | 76 |
| 2019 July | 37 | 27 | 64 |
| 2019 June | 1 | 0 | 1 |
| 2019 May | 1 | 0 | 1 |
| 2019 April | 1 | 2 | 3 |
| 2019 March | 10 | 4 | 14 |
| 2019 February | 18 | 2 | 20 |
| 2019 January | 26 | 22 | 48 |
| 2018 December | 46 | 50 | 96 |
| 2018 November | 0 | 18 | 18 |
| 2018 October | 0 | 16 | 16 |
| 2018 September | 0 | 7 | 7 |
| 2018 August | 0 | 22 | 22 |
| 2018 July | 0 | 4 | 4 |
| 2018 May | 0 | 2 | 2 |
| 2018 April | 0 | 15 | 15 |
| 2018 March | 0 | 25 | 25 |
| 2018 February | 0 | 17 | 17 |
| 2018 January | 0 | 12 | 12 |
| 2017 December | 0 | 21 | 21 |
| 2017 November | 0 | 19 | 19 |
| 2017 October | 0 | 25 | 25 |
| 2017 September | 0 | 30 | 30 |
| 2017 August | 0 | 27 | 27 |
| 2017 July | 0 | 36 | 36 |
| 2017 June | 0 | 93 | 93 |
| 2017 May | 0 | 7 | 7 |
Show all
